Seelos Therapeutics Inc (SEEL)
0.72
+0.02
(+2.86%)
USD |
OTCM |
Nov 14, 15:56
Seelos Therapeutics Net Income (TTM): 4.091M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.091M |
| March 31, 2024 | -27.12M |
| December 31, 2023 | -37.88M |
| September 30, 2023 | -51.09M |
| June 30, 2023 | -81.19M |
| March 31, 2023 | -72.96M |
| December 31, 2022 | -73.53M |
| September 30, 2022 | -82.14M |
| June 30, 2022 | -73.35M |
| March 31, 2022 | -60.93M |
| December 31, 2021 | -66.05M |
| September 30, 2021 | -45.24M |
| June 30, 2021 | -38.51M |
| March 31, 2021 | -33.38M |
| December 31, 2020 | -19.10M |
| September 30, 2020 | -23.31M |
| June 30, 2020 | -22.44M |
| March 31, 2020 | -20.58M |
| December 31, 2019 | -51.26M |
| September 30, 2019 | -47.58M |
| June 30, 2019 | -45.46M |
| March 31, 2019 | -45.87M |
| December 31, 2018 | -12.63M |
| September 30, 2018 | -8.091M |
| June 30, 2018 | -10.83M |
| Date | Value |
|---|---|
| March 31, 2018 | -10.02M |
| December 31, 2017 | 0.321M |
| September 30, 2017 | 2.468M |
| June 30, 2017 | 5.009M |
| March 31, 2017 | 3.145M |
| December 31, 2016 | -7.433M |
| September 30, 2016 | -9.466M |
| June 30, 2016 | -13.21M |
| March 31, 2016 | -15.12M |
| December 31, 2015 | -19.02M |
| September 30, 2015 | -33.98M |
| June 30, 2015 | -32.06M |
| March 31, 2015 | -24.94M |
| December 31, 2014 | -21.79M |
| September 30, 2014 | -5.843M |
| June 30, 2014 | -5.715M |
| March 31, 2014 | -11.53M |
| December 31, 2013 | -16.94M |
| September 30, 2013 | -35.23M |
| June 30, 2013 | -34.74M |
| March 31, 2013 | -35.73M |
| December 31, 2012 | -31.77M |
| September 30, 2012 | -16.82M |
| June 30, 2012 | -16.55M |
| March 31, 2012 | -19.42M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-82.14M
Minimum
Sep 2022
4.091M
Maximum
Jun 2024
-46.10M
Average
-45.24M
Median
Sep 2021
Net Income (TTM) Benchmarks
| 180 Life Sciences Corp | -12.55M |
| Cassava Sciences Inc | -17.66M |
| Cara Therapeutics Inc | -111.08M |
| Citius Pharmaceuticals Inc | -38.29M |
| Moleculin Biotech Inc | -25.17M |